Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 4.34%458.7M | 8.16%442.17M | 8.53%407.77M | 9.50%1.68B | 18.91%459.49M | 0.79%439.6M | 2.54%408.83M | 18.77%375.71M | -19.99%1.54B | -9.04%386.4M |
| Revenue from customers | 4.34%458.61M | 8.16%442.14M | 8.53%407.69M | 9.50%1.68B | 18.92%459.43M | 0.79%439.55M | 2.54%408.77M | 18.77%375.66M | -19.99%1.54B | -9.04%386.35M |
| Other cash income from operating activities | 78.85%93K | -40.74%32K | 50.00%81K | 4.00%216.1K | 4.28%56.1K | -1.89%52K | 1.89%54K | 12.50%54K | -32.73%207.79K | 19.77%53.79K |
| Cash paid | -11.19%-389.92M | -10.24%-365.21M | -6.63%-324.64M | -11.22%-1.4B | -29.70%-412.56M | 1.37%-350.68M | -12.76%-331.28M | -4.82%-304.46M | 24.44%-1.26B | 10.46%-318.08M |
| Payments to suppliers for goods and services | -11.19%-389.92M | -10.24%-365.21M | -6.63%-324.64M | -11.22%-1.4B | -29.70%-412.56M | 1.37%-350.68M | -12.76%-331.28M | -4.82%-304.46M | 24.44%-1.26B | 10.46%-318.08M |
| Direct dividend paid | ||||||||||
| Direct dividend received | 0 | 0 | ||||||||
| Direct interest paid | -227.85%-1.75M | -410.09%-2.93M | -233.22%-2.01M | 11.02%-2.22M | 17.69%-506.29K | 13.71%-535K | 8.87%-575K | 3.99%-602K | -4.16%-2.49M | 5.16%-615.07K |
| Direct interest received | 4.08%2.35M | 11.21%2.42M | 27.61%2.47M | 6.26%8.78M | 12.05%2.41M | 3.06%2.25M | 0.79%2.18M | 9.86%1.94M | -2.44%8.26M | 9.48%2.15M |
| Direct tax refund paid | 16.90%-5.98M | -2.43%-6.62M | -85.91%-23.38M | 14.95%-43.02M | 34.60%-16.79M | 44.66%-7.2M | -121.58%-6.46M | -39.84%-12.58M | -1.28%-50.59M | -12.78%-25.67M |
| Operating cash flow | -24.03%63.4M | -3.93%69.83M | 0.34%60.22M | 5.66%248.18M | -27.49%32.04M | 20.63%83.45M | -29.78%72.69M | 233.24%60.01M | 10.27%234.89M | -8.18%44.19M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 34.86%-9.7M | -12.04%-11.56M | 36.84%-9.09M | -19.79%-51.07M | 28.85%-11.47M | -23.11%-14.89M | -61.33%-10.32M | -79.51%-14.39M | 32.34%-42.63M | 7.16%-16.13M |
| Net business purchase and sale | --0 | --0 | 106.37%575K | ---9.03M | --0 | --0 | --0 | ---9.03M | --0 | --0 |
| Net investment product transactions | -17.14%-63.25M | -878.09%-33.96M | -153.61%-19.48M | 63.35%-26.89M | -56.61%-13.59M | -7,691.34%-53.99M | 104.92%4.36M | 47.60%36.33M | -20.39%-73.37M | 85.61%-8.68M |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 107.30%5.5K | -94.21%500 |
| Investing cash flow | -5.90%-72.95M | -664.57%-45.52M | -316.75%-28M | 25.01%-86.98M | -1.05%-25.06M | -438.97%-68.88M | 93.73%-5.95M | -22.19%12.92M | 1.53%-116M | 65.28%-24.81M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 0.00%-2.5M | 16.67%-2.5M | 0.00%-2.5M | 1,665.24%109.5M | 23,353.29%117.5M | 0.00%-2.5M | -20.01%-3M | 0.00%-2.5M | 12.51%-7M | 120.05%501K |
| Net common stock issuance | -59.13%459K | -28.02%131K | 152.48%9.46M | -13.21%6.86M | -46.78%1.81M | -16.26%1.12M | -93.75%182K | 1,358.37%3.75M | 252.54%7.9M | 3,825.63%3.39M |
| Cash dividends paid | --0 | ---- | ---- | -20.80%-175.55M | -101.23%-97.62M | --0 | ---48.75M | 39.65%-29.18M | -7.40%-145.33M | -0.33%-48.51M |
| Cash dividends for minorities | -19.37%-9.06M | 48.18%-6.27M | ---480K | 17.75%-28.09M | -4.27%-8.41M | -1.61%-7.59M | ---12.09M | --0 | -23.13%-34.15M | -1.43%-8.06M |
| Net other fund-raising expenses | -275.00%-15K | -180.00%-14K | -225.00%-13K | -829.36%-948.26K | -15,518.94%-935.26K | -102.76%-4K | ---5K | 55.56%-4K | 1,118.42%130.01K | ---5.99K |
| Financing cash flow | -23.91%-11.12M | 9.27%-57.77M | 123.16%6.47M | 50.56%-88.22M | 123.44%12.35M | 84.25%-8.97M | -249.73%-63.67M | 44.79%-27.94M | -5.70%-178.44M | 10.28%-52.68M |
| Net cash flow | ||||||||||
| Beginning cash position | 13.56%252.58M | 30.40%286.03M | 41.86%247.33M | -25.46%174.35M | 9.80%228.01M | 6.82%222.41M | 0.66%219.35M | -25.46%174.36M | -23.93%233.9M | -34.27%207.66M |
| Current changes in cash | -469.35%-20.67M | -1,189.93%-33.45M | -14.00%38.69M | 222.55%72.98M | 158.03%19.32M | 1,106.29%5.6M | 131.65%3.07M | 381.29%44.99M | 19.09%-59.55M | 59.40%-33.3M |
| End cash Position | 1.71%231.91M | 13.56%252.58M | 30.40%286.03M | 41.86%247.33M | 41.86%247.33M | 9.80%228.01M | 6.82%222.41M | 0.66%219.35M | -25.46%174.35M | -25.46%174.35M |
| Free cash flow | -21.66%53.7M | -6.41%58.26M | 12.75%51.09M | 1.66%193.59M | -36.61%17.49M | 20.65%68.55M | -35.54%62.25M | 378.89%45.31M | 27.64%190.43M | -25.38%27.58M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.